{"disease":{"id":"presbyopia","name":"presbyopia"},"drugs":{"marketed":[{"drug_id":"aceclidine","indication_name":"Presbyopia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aceclidin","generic_name":"ACECLIDINE","company_name":"","drug_phase":"marketed","molecular_target":"muscarinic receptors","drug_class":"aceclidine","quality_score":44,"revenue":null,"mechanism":"VIZZ, a pupil-selective miotic, contracts the iris sphincter muscle to improve vision by extending depth of focus."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03135327","title":"Clinical Applications of Advanced Ophthalmic Imaging","phase":"NA","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT03733730","title":"Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs","phase":"NA","overall_status":"COMPLETED","enrollment_count":2449,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT04654013","title":"PROductivity Study of Presbyopia Elimination in Rural-dwellers III","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1291,"lead_sponsor_name":"Queen's University, Belfast","has_results":false},{"nct_id":"NCT03719196","title":"Reading Glass on Livelihoods and Quality of Life in Rural Bangladesh","phase":"NA","overall_status":"COMPLETED","enrollment_count":824,"lead_sponsor_name":"Brac","has_results":false},{"nct_id":"NCT04629820","title":"PROductivity Study of Presbyopia Elimination in Rural-dwellers II","phase":"NA","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Queen's University, Belfast","has_results":false},{"nct_id":"NCT03228199","title":"PROductivity Study of Presbyopia Elimination in Rural-dwellers (PROSPER)","phase":"NA","overall_status":"COMPLETED","enrollment_count":751,"lead_sponsor_name":"Congdon Nathan","has_results":false},{"nct_id":"NCT05135286","title":"Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":629,"lead_sponsor_name":"Visus Therapeutics","has_results":false},{"nct_id":"NCT06542497","title":"Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":569,"lead_sponsor_name":"Ocuphire Pharma, Inc.","has_results":false},{"nct_id":"NCT05656027","title":"Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":469,"lead_sponsor_name":"LENZ Therapeutics, Inc","has_results":true},{"nct_id":"NCT03633695","title":"Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens","phase":"NA","overall_status":"COMPLETED","enrollment_count":453,"lead_sponsor_name":"AcuFocus, Inc.","has_results":true},{"nct_id":"NCT06060041","title":"IC-8 Apthera IOL New Enrollment Post Approval Study","phase":"","overall_status":"RECRUITING","enrollment_count":435,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":false},{"nct_id":"NCT03857542","title":"A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":427,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT02374671","title":"A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":365,"lead_sponsor_name":"Refocus Group, Inc.","has_results":true},{"nct_id":"NCT05753189","title":"Phase 3 Safety Study for the Treatment of Presbyopia Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":362,"lead_sponsor_name":"LENZ Therapeutics, Inc","has_results":false},{"nct_id":"NCT05646719","title":"Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":333,"lead_sponsor_name":"Ocuphire Pharma, Inc.","has_results":true},{"nct_id":"NCT06451666","title":"Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":330,"lead_sponsor_name":"CSPC Ouyi Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03804268","title":"Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT04599933","title":"An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":309,"lead_sponsor_name":"Orasis Pharmaceuticals Ltd.","has_results":true},{"nct_id":"NCT04599972","title":"An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"Orasis Pharmaceuticals Ltd.","has_results":true},{"nct_id":"NCT05660577","title":"Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens","phase":"NA","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT06045299","title":"Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Corxel Pharmaceuticals","has_results":false},{"nct_id":"NCT03811249","title":"Long Term Follow-up of the VisAbility™ Micro Insert System for Presbyopic Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Refocus Group, Inc.","has_results":true},{"nct_id":"NCT04806503","title":"A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia.","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":234,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04983589","title":"A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT05728944","title":"Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"LENZ Therapeutics, Inc","has_results":true},{"nct_id":"NCT06166901","title":"Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)","phase":"NA","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT04733014","title":"Perceptions of Ophthalmologists Regarding Contemporary Presbyopia Management.","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Democritus University of Thrace","has_results":false},{"nct_id":"NCT06597292","title":"The VIS Opti-K Low Vision Aid Device Provides Vision Improvement.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"VIS, Inc.","has_results":false},{"nct_id":"NCT05758883","title":"Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)","phase":"","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"AcuFocus, Inc.","has_results":false},{"nct_id":"NCT02310126","title":"Handling Comparison Between Two Contact Lens Types","phase":"NA","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Johnson & Johnson Vision Care, Inc.","has_results":true},{"nct_id":"NCT06483113","title":"DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study","phase":"","overall_status":"TERMINATED","enrollment_count":192,"lead_sponsor_name":"Alcon Research","has_results":false},{"nct_id":"NCT03118934","title":"Assessing Fitting Guides in Alcon Multifocal Contact Lenses","phase":"NA","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT05270863","title":"Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":182,"lead_sponsor_name":"Visus Therapeutics","has_results":true},{"nct_id":"NCT04755231","title":"Post-Market Clinical Study of the PanOptix Intraocular Lens (IOL) in a Chinese Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":181,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT05393895","title":"An Evaluation of the Safety of CSF-1 in Presbyopic Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Orasis Pharmaceuticals Ltd.","has_results":true},{"nct_id":"NCT03885011","title":"A Multi-Center, Double-Masked Evaluation of the Efficacy and Safety of CSF-1 in the Treatment of Presbyopia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"Orasis Pharmaceuticals Ltd.","has_results":true},{"nct_id":"NCT02595528","title":"A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT02780115","title":"A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03341923","title":"Clinical Evaluation of DAILIES TOTAL 1® Multifocal Compared to 1-Day Acuvue® Moist® Multifocal in a Japanese Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"Alcon Research","has_results":true},{"nct_id":"NCT04675151","title":"Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Ocuphire Pharma, Inc.","has_results":true},{"nct_id":"NCT05114486","title":"Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Eyenovia Inc.","has_results":false},{"nct_id":"NCT04265846","title":"Prospective Clinical Study of Different Intraocular Lens Implantation Designed for the Correction of Presbyopia","phase":"","overall_status":"UNKNOWN","enrollment_count":140,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT04172935","title":"Productivity Study of Presbyopia Improvement in Textile Workers","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":136,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT06702020","title":"VIS Opti-K Vision Improvement for Presbyopes","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":135,"lead_sponsor_name":"VIS, Inc.","has_results":false},{"nct_id":"NCT04875455","title":"Premium Trifocal IOL Comparative Analysis","phase":"NA","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"Beaver-Visitec International, Inc.","has_results":false},{"nct_id":"NCT05411341","title":"Comparison of Two Different Optical Biometric Systems","phase":"","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"Democritus University of Thrace","has_results":false},{"nct_id":"NCT07008768","title":"The Purpose is to Evaluate Visual Acuity for Distance, Intermediate and Near and Additionally Contrast Sensitivity at 25% and 10% of Illumination After Implantation of Trifocal IOL, Extended Range of Vision IOL, Bifocal IOL With Low Addition and Monofocal IOL","phase":"NA","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"University Eye Hospital Svjetlost","has_results":false},{"nct_id":"NCT02965833","title":"CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers","phase":"NA","overall_status":"COMPLETED","enrollment_count":126,"lead_sponsor_name":"Alcon, a Novartis Company","has_results":true},{"nct_id":"NCT03809611","title":"A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05124275","title":"Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"Glaukos Corporation","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}